NDRG3 and neoplasm: In both HCC cohorts, patients were divided into four groups based on miR-192-5p expression in their tumor tissues (HCC192Low and HCC192High, medium cut-off) and levels of NDRG3 and MCT1 in non-tumor tissues (NTHigh_NDRG3 or MCT1 and NT Low_NDRG3 and MCT1, medium cut-offs).